Studying intrapulmonary pharmacokinetics for tuberculosis treatment: a systematic review of methodology
Many of the identified methods are associated with considerable limitations including invasiveness, complexity, cost and lack of standardization. Most importantly, the method of choice must provide adequate representation of site of disease pharmacokinetics. Determining the best approach for studying intrapulmonary pharmacokinetics involves careful consideration of all these factors.
Authors
- Haini Wen (ORCID: https://orcid.org/0000-0003-2797-2128)
- Elin M. Svensson (ORCID: https://orcid.org/0000-0002-0093-6445)
- Lindsey H. M. te Brake (ORCID: https://orcid.org/0000-0001-7727-2846)
- Rob E. Aarnoutse (ORCID: https://orcid.org/0000-0001-8925-969X)
- Cécile Magis-Escurra
- Isabella van der Feltz (ORCID: https://orcid.org/0000-0002-3769-2042)
Institutions
- Uppsala University (SE)
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1093/jac/dkaf274
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.40